Correlation Engine 2.0
Clear Search sequence regions

filter terms:
Sizes of these terms reflect their relevance to your search.

There have been numerous advances in the development of computational and statistical methods and applications of big data and artificial intelligence (AI) techniques for computer-aided drug design (CADD). Drug design is a costly and laborious process considering the biological complexity of diseases. To effectively and efficiently design and develop a new drug, CADD can be used to apply cutting-edge techniques to various limitations in the drug design field. Data pre-processing approaches, which clean the raw data for consistent and reproducible applications of big data and AI methods are introduced. We include the current status of the applicability of big data and AI methods to drug design areas such as the identification of binding sites in target proteins, structure-based virtual screening (SBVS), and absorption, distribution, metabolism, excretion and toxicity (ADMET) property prediction. Data pre-processing and applications of big data and AI methods enable the accurate and comprehensive analysis of massive biomedical data and the development of predictive models in the field of drug design. Understanding and analyzing biological, chemical, or pharmaceutical architectures of biomedical entities related to drug design will provide beneficial information in the biomedical big data era. © 2022 The Author(s).


Jai Woo Lee, Miguel A Maria-Solano, Thi Ngoc Lan Vu, Sanghee Yoon, Sun Choi. Big data and artificial intelligence (AI) methodologies for computer-aided drug design (CADD). Biochemical Society transactions. 2022 Feb 28;50(1):241-252

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35076690

View Full Text